Tian Zeng
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 2
-
- Cancer Immunotherapy and Biomarkers 3
-
- Epigenetics and DNA Methylation 5
- Circular RNAs in diseases 3
- DNA Repair Mechanisms 2
-
- Ferroptosis and cancer prognosis 2
-
- Lipid metabolism and disorders 2
- Partner nations
- China
In The Last Decade
Tian Zeng
25 papers receiving 344 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 99
- Oncology 90
- Molecular Biology 184
- Immunology 48
- Reproductive Medicine 17
Countries citing papers authored by Tian Zeng
This map shows the geographic impact of Tian Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Zeng more than expected).
Fields of papers citing papers by Tian Zeng
This network shows the impact of papers produced by Tian Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Zeng. The network helps show where Tian Zeng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tian Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 44 | |
| 7 | 2024 | 28 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 15 | |
| 10 | 2023 | 9 | |
| 11 | 2022 | 18 | |
| 12 | 2022 | 12 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 3 | |
| 15 | 2021 | 37 | |
| 16 | 2020 | 18 | |
| 17 | LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway. | 2019 | 7 |
| 18 | 2018 | 31 | |
| 19 | Low PBRM1 identifies tumor progression and poor prognosis in breast cancer. | 2015 | 10 |
| 20 | 2012 | 7 |
About Tian Zeng
Tian Zeng is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 29 papers that have together received 344 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Circular RNAs in diseases (3 papers), DNA Repair Mechanisms (2 papers), MicroRNA in disease regulation (2 papers), Ferroptosis and cancer prognosis (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Cancer Research (99 citations), Oncology (90 citations) and Molecular Biology (184 citations). Tian Zeng has collaborated with scholars based in China. Frequent co-authors include Juan Zou, Zufan Zhang, Shaohui Sun, Yukun Li, Yukun Li, Wenchao Zhou, Juan Zou, Dan Mo, Guan Yang and Hui Ling. Their work appears in journals such as Analytical Chemistry, Scientific Reports and Analytica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.